• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson posts quarterly revenue increase

Article

Strong performance in some international markets helped drive a 5.8% increase in sales for ultrasound vendor Acuson in its second quarter. For the period (end-July), Acuson booked revenues of approximately $119.9 million, compared with $113.3 million in

Strong performance in some international markets helped drive a 5.8% increase in sales for ultrasound vendor Acuson in its second quarter. For the period (end-July), Acuson booked revenues of approximately $119.9 million, compared with $113.3 million in the second quarter of 1998. The company’s net income was $4.7 million, compared with $4.1 million in the same period last year.

Overall, the company’s revenues grew 5% in the U.S. and 9% worldwide. Acuson attributed its revenue growth to an increase in equipment sales in the U.S. and in some international markets, such as Japan and Canada. The launch of its new PACS offering, KinetDx (SCAN 5/12/99), also helped influence scanner sales, according to the Mountain View, CA-based firm. Shipments of KinetDx are set to begin in the fourth quarter.

In other plans for the second half of 1999, Acuson will introduce in the third quarter Imagegate Advanced Performance Option, a new release for the firm’s Sequoia and Aspen ultrasound systems.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.